Trials / Completed
CompletedNCT07066176
Establishing and Validating a Meal-provoked Intestinal Permeability Test for Nutritional and Metabolic Health Clinical Research.
Development of Intestinal Permeability Tests for Clinical Nutrition and Metabolic Health Studies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Development of Intestinal Permeability Tests for Clinical Nutrition and Metabolic Health Studies
Detailed description
Crossover clinical trial on 10 subjects (5 women, 5 men) with 3 intestinal permeability tests (3-day washout) as follows: 1) fasting; 2) meal-provoked; and 3) meal-provoked with acute aspirin challenge to assess the test's feasibility and capacity to detect alterations in intestinal permeability after aspirin-induced intestinal barrier defects. Each test will be performed after a 12h fast. Subjects will provide fasting blood and urine samples, fully empty their bladders and drink 50mL of water with/without soluble aspirin (650mg). After 30 min., subjects will drink 500mL of water or mixed meal beverage (22g protein, 26g fat, 52g carbs) with mannitol (2g) and lactulose (4g). A standardized snack and water (200mL) will be provided at 3h. Blood samples will be taken at 2h, 3h and 4h. All urine will be collected over 5 hours. Collection times were adapted to account for potential delays in gastric emptying (mixed meal vs. water). Lactulose-to-mannitol ratios, by HPAEC-PAD method, in urine and blood will be compared by phases using mixed linear models.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | Aspirin 650mg prior mixed meal beverage |
| DIETARY_SUPPLEMENT | Mixed meal beverage | Mixed meal beverage |
Timeline
- Start date
- 2025-07-07
- Primary completion
- 2025-08-15
- Completion
- 2025-08-15
- First posted
- 2025-07-15
- Last updated
- 2025-09-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07066176. Inclusion in this directory is not an endorsement.